Oral Progestins Control Heavy Periods in Young Patients
In a retrospective study, young people with bleeding disorders responded best to oral progestins among the treatments tested.
Updated on Nov. 3, 2026 in Women’s Health

A retrospective study of 121 adolescents and young adults with bleeding disorders and heavy menstrual bleeding found oral progestins controlled bleeding in 89.8% of cases, outperforming other treatments evaluated. The findings, published October 21, 2026 in the Journal of Adolescent Health, may inform care for young patients with these conditions.
Why it matters
Heavy menstrual bleeding is a common and disruptive problem for young people with bleeding disorders, and many need several treatment attempts before it is controlled. Evidence comparing treatment options in this age group has been limited, so a head-to-head look at what worked best offers practical guidance for clinicians and families.
This retrospective study reviewed 121 adolescents and young adults with confirmed bleeding disorders and heavy menstrual bleeding, referred between 2016 and 2023 and followed for one to nine years. Efficacy was measured over a 90-day reference period, comparing oral progestins, the levonorgestrel-releasing intrauterine system, and oral contraceptive pills.
The players
Peking University First Hospital
A leading teaching hospital in Beijing, China, where the study's lead researcher works and where the joint pediatric gynecology and pediatric hematology clinic is based.
The details
Progestins are synthetic forms of the hormone progesterone that thin the lining of the uterus, which reduces the volume of menstrual bleeding. In this study, efficacy was defined as achieving any of four bleeding patterns, ranging from no bleeding at all to lighter bleeding. Von Willebrand disease, a common inherited clotting disorder, was the most frequent diagnosis, affecting 81 patients, while immune thrombocytopenia affected 24.
Timeline
Patients were referred to the joint clinic between 2016 and 2023.
The study was published online on October 21, 2026, in the Journal of Adolescent Health.
Health Landscape
Heavy menstrual bleeding in people with bleeding disorders has historically been managed with a trial-and-error approach, and this study adds comparative efficacy data for a younger population. The findings sit alongside a broader push to identify effective first-line options that reduce the number of regimens patients must try.
If you or a young person you care for has a bleeding disorder and heavy periods, this study suggests oral progestins may be worth discussing with a doctor as a treatment option. Because many patients needed more than one regimen, tracking how well each approach works and staying in close contact with a clinician can help.
The takeaway
Oral progestins showed the highest bleeding-control rate among the options studied for this group. Anyone managing heavy periods with a bleeding disorder should discuss these findings with a physician to decide which approach fits their situation.
Further reading
Explore more coverage in our Women's Health section.
Source note: This article includes information reported by Medscape.


